Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Cash from Investing Activities (2020 - 2026)

Biomea Fusion (BMEA) posted Cash from Investing Activities of $550000.0 for Q1 2026, up 770.73% sequentially from -$82000.0 in Q4 2024.

Biomea Fusion (BMEA) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Cash from Investing Activities for 6 years, with the latest figure at $550000.0 in Q1 2026.

  • Quarterly Cash from Investing Activities changed N/A year-over-year to $550000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $550000.0 (up 268.2% YoY) and the FY2024 annual result came in at -$362000.0, up 83.69% from the prior year.
  • Cash from Investing Activities advanced to $550000.0 in Q1 2026 per BMEA's latest filing, from -$82000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $20.4 million in Q1 2022 and troughed at -$1.8 million in Q1 2023.
  • A 4-year average of $1.9 million and a median of -$39000.0 in 2023 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities surged 984.56% in 2022, then tumbled 925.0% in 2024.
  • Over 4 years, Cash from Investing Activities stood at -$701000.0 in 2022, then jumped by 98.86% to -$8000.0 in 2023, then sank by 925.0% to -$82000.0 in 2024, then soared by 770.73% to $550000.0 in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered $550000.0, -$82000.0, and -$186000.0 for Q1 2026, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 Biomea Fusion 97.69 Mn 97.69 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 550,000.00
Mar 31, 2026 550,000.00
Dec 31, 2024 -82,000.00
Dec 31, 2024 -82,000.00
Sep 30, 2024 -186,000.00
Sep 30, 2024 -186,000.00
Jun 30, 2024 -59,000.00
Jun 30, 2024 -59,000.00
Mar 31, 2024 -35,000.00
Mar 31, 2024 -35,000.00
Dec 31, 2023 -8,000.00
Dec 31, 2023 -8,000.00
Sep 30, 2023 -39,000.00
Sep 30, 2023 -39,000.00
Jun 30, 2023 -417,000.00
Jun 30, 2023 -417,000.00
Mar 31, 2023 -1.76 Mn
Mar 31, 2023 -1.76 Mn
Dec 31, 2022 -701,000.00
Dec 31, 2022 -701,000.00